USPTO Patents Application 09876958

A

sase type a plus (+) inside this box ■

! O

! C

PTO/SB/29 (12/97)
Approved for use through 09/30/00. OMB 0651-0032
Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE

= 3 UTILITY
— ° PATENT APPLICATION
TRANSMITTAL

(Only for new nonprovisional applications under 37 CFR 1.53(b))

Attorney Docket No.

8740-064-999

Tbfa/ Pages

140

First Named Inventor or Application Identifier p =

Glowny, David A. et a

Express Mail Label No.

EL 501 640 176 US m S5 =^

I m,E— — _™ W

J eo =q

APPLICATION ELEMENTS

See MPEP chapter 600 concerning utility patent application contents.

Assistant Commissioner for-Pateij^z
ADDRESS TO: Box Patent Application =2
Washington, DC 20231 =^=^

Fee Transmittal Form [Total Sheets 4 l

Submit an original, and a duplicate for fee processing)

Specification [Total Pages 101 1

(preferred arrangement set forth below)

-Descriptive title of the Invention

-Cross Reference to Related Applications

-Statement Regarding Fed sponsored R&D

-Reference to Microfiche Appendix

-Background of the Invention

-Brief Summary of the Invention

-Brief Description of the Drawings (if filed)

-Detailed Description of the Invention (including drawings, if filed)

-Claim(s)

-Abstract of the Disclosure

Drawing(s) (35 USC 1 13) [Total Sheets 291

6. □ Microfiche Computer Program (Appendix)

7. □ Nucleotide and/or Amino Acid Sequence Submission

(if applicable, all necessary)

a. □ Computer Readable Copy

b. □ Paper Copy (identical to computer copy)

c. □ Statement verifying identity of above copies

3.;;

4..-. h Oath or Declaration

[Total Sheets _2J

I a. □ Newly executed (original or copy)

\ b. si Copy from a prior application (37 CFR 1 .63(d))

(for continuation/divisional with Box 17 completed)

[Note Box 5 below]

i. □ DELETION OF INVENTORS(S)

Signed statement attached deleting inventor(s) named in the prior
application, see 37 CFR 1.63(d)(2) and 1.33 (b).

; b Incorporation By Reference (useable if Box 4b is checked)

The entire disclosure of the prior application, from which a copy of the oath
or declaration is supplied under Box 4b, is considered as being part of the
disclosure of the accompanying application and is hereby incorporated by
reference therein.

ACCOMPANYING APPLICATION PARTS

8. □ Assignment Papers (cover sheet & documents))

9. □ 37 CFR 3.73(b) Statement □ Power of Attorney

(when there is an assignee)

10. □ English Translation Document (if applicable)

11. □ Information Disclosure □ Copies of IDS

Statement (IDS)/PTO-1449 Citations

12. h Preliminary Amendment [Total Sheets _3_]

13. a Return Receipt Postcard (MPEP 503)

(Should be specifically itemized)

14. □ Small Entity □ Statement filed in prior application,

Statement(s) Status still proper and desired

15. o Certified Copy of Priority Document(s)

(if foreign priority is claimed)

16. □ Other:

17. If a CONTINUING APPLICATION, check appropriate box and supply the requisite information:

a Continuation □ Divisional □ Continuation-in-part (CIP) of prior application No: 09/328,294 filed June 8, 1999.

18. CORRESPONDENCE ADDRESS

E Customer Number or Bar Code Label

20583

(Insert Customer No. or Attach bar code label here)

or □ Correspondence address below

NAME

ADDRESS

CITY

STATE

ZIP CODE

COUNTRY

TELEPHONE

FAX

Burden Hour Statement This form is estimated to take 0.2 hours to complete. Time will vary dependingupon the needs of the individual case. Any comments on
the amount of time you are required to complete this form should be sent to the Chief Information Officer, Patent and Trademark Office, Washington, DC 20231 . DO
NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: AssistantCommissionerfor Patents, Box Patent Application, Washington, DC 20231 .

NY2- 1206350.1

PENNIE & EDMONDS llp DOCKET NO. 8740-064

Express Mail No.: EL 501 640 176 US

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE

Prior application: Examiner Scott L. Weaver

Art Unit 2748

Assistant Commissioner for Patents
Box PATENT APPLICATION
Washington, D.C. 20231

Sir:

This is a request for filing a E continuation □ divisional application under 37 CFR § 1.53(b), of
pending prior application no. 09/328,294 filed on June 8, 1999.

of Glowny. David et al.

f =: (inventor(s) currently ot record in prior application)

fif or A System and Method for Integrating Call Record Information

~~l (title ot invention)

% 1. a The filing fee is calculated below:

PATENT APPLICATION FEE VALUE

TYPE

NO. FILED

LESS

EXTRA

EXTRA RATE

FEE

Total Claims

26

-20

6

$18.00 each

$ 108.00

Independent

3

-3

0

$80.00 each

$ 0.00

Basic Fee

$ 710.00

Multiple Dependency Fee
If Applicable ($260.00)

$ 0.00

Total

$ 818.00

50% Reduction for Independent Inventor, Nonprofit Organization or Small
Business Concern

$ 0.00

Total Filing Fee

$ 818.00

2. h Please charge the required fee to Pennie & Edmonds llp Deposit Account

No. 16-1 150. A copy of this sheet is enclosed.

3. b Amend the specification by inserting before the first line the following

sentence: This is a continuation of application no. 09/328,294, filed June
8, 1999.

4a. o Transfer the drawings from the prior application to this application and
abandon the prior application as of the filing date accorded this

NY2- 1206354.1

PENNIE & EDMONDS llp DOCKET NO. 8740-064

application. A duplicate copy of this sheet is enclosed for filing in the
prior application file.

4b. a New formal drawings are enclosed.

4c. □ Informal drawings are enclosed.

5a. □ Priority of application no. filed on in is claimed under 35 U.S.C. §119.

5b. □ The certified copy has been filed in prior application no. , filed .

6. e The prior application is assigned of record to Dictaphone Corporation.

7a. e The Power of Attorney appears in the original papers in the prior
application no. 09/328,294, filed June 8, 1999. A copy is enclosed.

7b. □ Since the Power of Attorney does not appear in the original papers, a
copy of the Power in prior application no. , filed is enclosed.

8. □ This application contains nucleic acid and/or amino acid sequences

required to be disclosed in a Sequence Listing under 37 CFR §§1 .821-
1 .825. It is requested that the Sequence Listing in computer readable
form from prior application no., filed on be made a part of the present
application as provided for by 37 C.F.R. § 1.821(e). The sequences
disclosed therein are the same as the sequences disclosed in this
application. A copy of the paper Sequence Listing from application no.
is enclosed.

9. □ The undersigned states, under 37 C.F.R. §1. 821(f), that the content of the

enclosed paper Sequence Listing from application no. is the same as the
content of the computer readable form submitted in application no. .

10. B Additional enclosures or instructions: A preliminary amendment is

enclosed, and another copy of the specification is enclosed.

Respectfully submitted,

Date June 8,2001

S~ ^ 32,110

f*f ^Edmond R. Bannon (Reg. No.)

PENNIE & EDMONDS llp
1155 Avenue of the Americas
New York, N.Y. 10036-271 1
(212) 790-9090

-2-

NY2- 1206354.1